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One complication of malaria is increased susceptibility to invasive bacterial infections.
Plasmodium infections impair host immunity to non-Typhoid Salmonella (NTS) through
heme-oxygenase I (HO-I)-induced release of immature granulocytes and myeloid
cell-derived IL-10. Yet, it is not known if these mechanisms are specific to NTS. We
show here, that Plasmodium yoelii 17XNL (Py) infected mice had impaired clearance
of systemic Listeria monocytogenes (Lm) during both acute parasitemia and up to 2
months after clearance of Py infected red blood cells that was independent of HO-I
and IL-10. Py-infected mice were also susceptible to Streptococcus pneumoniae (Sp)
bacteremia, a common malaria-bacteria co-infection, with higher blood and spleen
bacterial burdens and decreased survival compared to naïve mice. Mechanistically,
impaired immunity to Sp was independent of HO-I, but was dependent on Py-induced
IL-10. Splenic phagocytes from Py infected mice exhibit an impaired ability to restrict
growth of intracellular Lm, and neutrophils from Py-infected mice produce less reactive
oxygen species (ROS) in response to Lm or Sp. Analysis also identified a defect in
a serum component in Py-infected mice that contributes to reduced production of
ROS in response to Sp. Finally, treating naïve mice with Plasmodium-derived hemozoin
containing naturally bound bioactive molecules, excluding DNA, impaired clearance of
Lm. Collectively, we have demonstrated that Plasmodium infection impairs host immunity
to diverse bacteria, including S. pneumoniae, through multiple effects on innate immunity,
and that a parasite-specific factor (Hz+bound bioactive molecules) directly contributes
to Plasmodium-induced suppression of antibacterial innate immunity.
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INTRODUCTION
Despite efforts to decrease the global health burden of malaria,
infections with Plasmodium species continue to cause over 200
million episodes of malaria each year (Organization WH, 2018).
These infections resulted in 435,000 deaths in 2017 the majority
of which occur in sub-Saharan Africa in children under the age of
5 years (OrganizationWH, 2018). In areas with endemic malaria,
an association between Plasmodium infection and invasive
bacterial infections has been reported, and malaria was identified
as a major risk factor for developing bacteremia that correlated
with a worse clinical outcome and higher morbidity (Berkley
et al., 2005; Reddy et al., 2010; Colombatti et al., 2011; Scott
et al., 2011; Were et al., 2011; Auma et al., 2013; Gomez-Perez
et al., 2014; Morton et al., 2018). These reports implicate both
gastrointestinal and pulmonary bacterial pathogens such as non-
typhoid Salmonella (NTS) and Streptococcus pneumoniae (Sp),
respectively, as the most common organisms isolated from blood
of Plasmodium and bacteria co-infected individuals (Berkley
et al., 2005; Reddy et al., 2010; Scott et al., 2011; Decuypere et al.,
2016; Mourembou et al., 2016).
Recent studies have characterized some of the underlying
mechanisms by which Plasmodium infections increase
susceptibility to invasive NTS infection (Cunnington et al.,
2011, 2012; Lokken et al., 2014, 2018; Mooney et al., 2014,
2018). First, Plasmodium-induced hemolysis results in the
activation of heme oxygense-1 (HO-1), which mobilizes
functionally immature granulocytes from the bone marrow.
These immature granulocytes exhibited impaired production
of reactive oxygen species in response to PMA stimulation,
and decreased killing of NTS (Cunnington et al., 2011). Similar
impairments to NTS immunity were observed when mice were
treated with phenylhydrazine to induce hemolysis or hemin
to mimic hemolysis, leading to the conclusion that impaired
bacterial immunity during Plasmodium infection is attributed
to hemolysis with no parasite-specific factor contributing
to immune suppression (Cunnington et al., 2012). Second,
Plasmodium-induced IL-10 from myeloid cells suppresses the
ability of myeloid cells to control NTS, resulting in increased
systemic colonization in co-infected mice (Lokken et al.,
2014). Moreover, IL-10 signaling can directly induce HO-1
to suppress anti-bacterial immunity, creating an environment
that favors intracellular growth and dissemination of NTS
(Lee and Chau, 2002). Importantly, it is not known whether
these mechanisms are unique to NTS co-infections versus
mechanisms that are generally applied to other systemic bacterial
infections. Furthermore, no parasite-specific factor has been
identified to contribute toward Plasmodium-induced impaired
immunity to bacterial co-infections. These represent important
knowledge gaps that impede treatment of bacteria co-infections
during malaria.
Digestion of hemoglobin results in the release of heme,
which is toxic to the parasite. Heme is detoxified within the
parasite’s digestive vacuole via non-enzymatic polymerization
into hemozoin (Hz), which is an insoluble crystal structure.
Following erythrocyte rupture, Hz is released into circulation
and engulfed by phagocytic cells resulting in deposition in
tissues and organs such as spleen, liver, brain, lungs, and bone
marrow. Hz deposition following Plasmodium berghei infection
was evident in the spleen, liver, bone marrow, and peripheral
blood 196 days after infection (Frita et al., 2012). Hz has
also been reported in lung and brain tissue of P. berghei and
Plasmodium chabaudi infected mice (Deroost et al., 2012). The
immune modulatory potential of Hz has been examined in
several studies with a wide variety of Hz preparations and cell
types being used. While synthetically generated Hz has been
described in some cases as “immunologically inert,” others have
found Hz formed naturally during erythrocyte infection to alter
and impair many immune cell functions (Parroche et al., 2007).
For example, uptake of parasitized red blood cells (RBCs) or
purified Hz by human monocyte-derived macrophages causes
impaired phagocytosis of additional RBCs or production of a
PMA-induced oxidative burst (Schwarzer et al., 1992), which
are impaired via Hz-dependent inactivation of protein kinase
C and NADPH-oxidase (Schwarzer et al., 1993; Schwarzer and
Arese, 1996). Internalization of Hz has also been found to
induce the production of pro-inflammatory cytokines such as
IL-1β and TNF and also increased chemokine production and
enhanced expression of their receptors (CCL3-5, MCP-1) in
mouse macrophages and human peripheral blood monocytes
(Sherry et al., 1995; Giribaldi et al., 2010). Antigen presentation
functions and overall functional maturation of dendritic cells are
also impacted, as decreased surface expression of CD54, CD11c,
and MHC-class II in human PBMCs following stimulation with
IFN-γ has also been observed during co-incubation with Hz
(Schwarzer et al., 1998). Few studies, however, have looked
directly at the interactions between innate immune cells and
Hz in the context of in vivo bacterial infection or the effect
of Hz on neutrophil function. Moreover, previous work has
shown impaired antimicrobial functions of innate immune
cells from African children with uncomplicated malaria that
lasted up to 8 weeks after antimalarial treatment (Cunnington
et al., 2012). Of note, there is unlikely to be parasite-induced
hemolysis during convalescence, which is the current hypothesis
by which Plasmodium suppresses anti-bacterial innate immunity.
Collectively, this leads to the hypothesis that Hz contributes
to Plasmodium-induced suppression of innate immunity to
bacterial infections.
We demonstrate here, a long-lasting defect in the clearance
of Listeria monocytogenes (Lm) from spleens of mice previously
infected with Plasmodium yoelii 17XNL (Py). This effect was
independent of IL-10 and HO-1. Py also induced long-lasting
impaired immunity to Sp, which resulted in decreased survival
compared to control mice. Py impaired control of Sp was
dependent on IL-10, but independent of HO-1. In addition to
the in vivo infections, we show that splenic neutrophils from
Py-infected mice have impaired ROS production in response
to both Lm and Sp, with a defective serum factor further
decreasing this response to Sp. Finally, we demonstrate that
“native” Hz isolated from Py convalescent mice (PyHz), defined
as Hz containing naturally associated bioactive molecules, such
as host and parasite-derived proteins and lipids but not DNA,
significantly impaired the ability of splenic phagocytes to control
growth of intracellular Lm. Both PyHz and “native” Hz isolated
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from P. falciparum-infected red blood cell cultures (PfHz) were
sufficient to impair clearance of Lm in vivo. Thus, we identified
a parasite-specific factor that directly contributes to impaired
immunity to a systemic bacterial infection.
MATERIALS AND METHODS
Mice
Female C57BL/6N mice 6–12 weeks old were obtained from
Charles River Laboratories (Wilmington, MA) and housed at
the University of Louisville under appropriate biosafety level
conditions. All mice were housed in a specific pathogen-
free facility and acclimatized for a minimum of 7 days
before starting experiments. Animals were fed the NIH-31 diet
(Modified Open Formula Mouse/Rat Irradiated Diet; Harlan
7,913; Envigo, Indianapolis, IN) and provided autoclaved, non-
acidified reverse-osmosis water ad libitum. The mice were kept
on a 12-h light/dark cycle from 6 AM to 6PM and 6PM to
6AM, respectively. All animal handling and experimentation
were reviewed and approved by the University of Louisville
Institutional Animal Care and Use Committee based on the
recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
Infections
Plasmodium yoelii
Mice were infected i.v. with 5 × 106 parasitized red blood
cells (pRBC) Plasmodium yoelii 17XNL (Py). Parasitemia (% of
infected red blood cells) was determined by analyzing samples
of peripheral blood obtained from day 5 post Py infection and
alternating days afterward until mice cleared detectable infected
RBCs. Blood samples were fixed in 0.02% glutaraldehyde and
stained with antibodies specific to CD45-APC (clone 104) and
Ly-76 (clone Ter119) from Biolegend (San Diego, CA) and dyes
dihydroethidium, and Hoechst 33342 (Sigma-Aldrich, St. Louis,
MO). Parasitemia was analyzed with flow cytometry using a
BD Fortessa, where pRBCs were identified as the population of
CD45−, Ter119+, dihydroethidium+, Hoechst+ cells. All flow
cytometry data was analyzed with FlowJo software.
Listeria monocytogenes
actA-deficient Listeria monocytogenes strain 10403S was grown
from freezer stock aliquot in tryptic soy broth and then washed
with PBS and resuspended in sterile saline. Mice were infected
i.v. with 5 × 106 CFU on indicated days post Py infection or as
an initial infection in age-matched mice.
Streptococcus pneumoniae
The following reagent was obtained through the NIH Biodefense
and Emerging Infections Research Resources Repository,
NIAID, NIH:
Streptococcus pneumoniae (Sp) ATCC strain 6303 a type 3
capsule isolate. Cultures were started from freezer stocks and
grown in brain heart infusion broth containing 50mM HEPES
buffer and incubated statically at 37◦C with 5% CO2. Cultures
were washed in PBS and resuspended in sterile saline. Mice were
infected with 1× 106 CFU of Sp intranasally to naïve mice or Py
infected mice on day seven post Py infection in a volume of 30
µl. Inoculum dose was confirmed by plating serial dilutions on
blood agar and counting colonies after 12–18 h of growth at 37◦C
with 5% CO2.
Bacterial Burden Quantification Analysis
Spleens and livers from Lm infected mice were collected in 4ml
0.2% IGEPAL (Sigma Aldrich, St. Louis, MO) at the indicated
timepoints. All organs were homogenized with a tissue master
homogenizer (Omni International, Kennesaw GA) and plated
in serial dilutions on tryptic soy agar plates with 50µg/mL
streptomycin. Lungs and spleens from Sp infected mice were
collected in sterile 1X PBS. Organs were homogenized and plated
in serial dilutions on tryptic soy agar plates supplemented with
10% citrated sheep blood (Hardy Diagnostics, Springboro, Ohio).
Peripheral blood was collected via retro-orbital bleed and plated
directly on tryptic soy agar plates with 10% sheep blood agar.
In vivo Inhibition of IL-10 and HO-1
Py-infected and naïve mice were injected i.p. with 300, 200,
and 100 µg of rat anti-IL-10 IgG1 kapa monoclonal antibody
(clone JES5-2A5) or rat anti-horseradish peroxidase IgG1 isotype
control (InVivoMAb, West Lebanon, NH) in 0.2mL sterile saline
on days Py+6, 7, and 8 for Lm co-infection (day Lm −1, 0,
and +1), days Py+7, 8, and 9 for Sp co-infection (day Sp −1,
0, and +1). Similarly, Py-infected and naïve mice were treated
i.p. with 40µmol/kg Tin Protoporphyrin IX (chloride) (Sn PP)
(Cayman Chemical, Ann Arbor, MI) in 0.2mL 1X PBS on days
Py+5, 6, 7, and 8 for Lm co-infection (day Lm −2, −1, 0, and
+1), days Py+6, 7, 8, and 9 for Sp co-infection (day Sp−2,−1, 0,
and+1).
Splenic Myeloid Cell Analysis
Spleens were removed on the indicated days post Py infection
or from age-matched naïve mice and placed in HyClone RPMI
1640 (Thermo Fisher Scientific, Waltham, MA) supplemented
with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville,
GA), 1.19 mg/ml HEPES (Corning, New York, NY), 0.2 mg/ml
L-glutamine (Research Products International, Mt. Prospect,
IL), 0.05M 2-mercaptoethanol (Thermo Fisher Scientific), 0.05
mg/mL penicillin/streptomycin (Invitrogen, Grand Island, NY),
and 0.05 mg/mL gentamicin (Corning). Single cell suspensions
were generated by manually disrupting spleens with the plunger
of a 5mL syringe over fine a wire mesh and then treated
with ammonium chloride potassium solution (0.15mM NH4Cl,
1.0mM KHCO3, 0.1mM Na2 EDTA, 1N HCl) to lyse red blood
cells and then washed in RPMI then resuspended in FACS buffer
(1XPBS, 1%FBS, 0.02% sodium azide) containing Fc block (anti-
CD16/32; clone 2.4G2). Splenocytes were then stained with cell
surface marker-specific antibodies. Anti-CD3ǫ FITC (clone 145-
2C11), anti-CD19 FITC (clone 6D5), anti-CD11b PE/Cy7 (clone
M1/70), anti-CD11c BV650 (clone N418), anti-Ly-6G BV421
(clone 1A8), anti-Ly-6C PerCP/Cy5.5 (clone AL-21), anti-F4/80
PE Dazzle 594 (clone BM8) were from Biolegend (San Diego,
CA). Anti-CD209b APC (clone eBio 22D1), anti-CD169 (clone
SER-4) were from eBiosciences (San Diego, CA). Anti-SIGLEC-
F APC R700 (clone E50-2240) was from BD Pharmingen (San
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Diego, CA). Cells were incubated with antibodies at 4◦C for
15min. Cells were then fixed in 4% paraformaldehyde fixation
buffer (Biolegend) and then washed three times in FACS buffer
before being analyzed on a BD LSRFortessa.
Spleen Phagocytic Cell Isolation and
Intracellular Bacterial Survival Assay
Single cell suspensions from 3 naïve or Py infected mice were
generated as described above and pooled together. Splenic
phagocytes were enriched by negative depletion of CD3+
and CD19+ cells using anti-CD3ǫ and anti-CD19 microbeads
(Miltenyi Biotec, Bergisch Gladbach, Germany), according
to manufacturer recommendations. CD3− and CD19− flow
through cells were stained with anti-CD11b PE/Cy7 (clone
M1/70) and CD11c APC (clone N418) from Biolegend (San
Diego, CA). CD11bhi/CD11c− cells were sort purified with a BD
FACSAria III. Sorted cells were plated and incubated at 37◦C
with 5% CO2 for 1 h. For some experiments, cells from naïve
mice were incubated for 30min with 30 µg Py hemozoin (PyHz).
Sorted cells were infected with Lm that had been opsonized
by incubating in RPMI with 10% homologous mouse serum
(naïve cells + Lm opsonized with naïve serum; Py cells +
Lm opsonized with Py serum) rotating for 30min at 37◦C.
Bacteria was washed once in RPMI and cells were infected
with a multiplicity of infection (MOI) = 100. One hour after
the infection, media was removed from cells and replaced with
RPMI containing 5µg/mL gentamicin to kill extracellular Lm.
Intracellular Lm burden was determined after 1 and 4 h of
incubation in RPMI with gentamicin by removing the media
containing gentamicin and resuspending the cells in sterile
deionized H2O (dH2O) to lyse cells and release surviving Lm.
Fold change in intracellular Lm was determined by dividing
cfu at 4 h post infection by cfu/well at 1 h after the addition
of gentamicin.
Microscopy
Cells were from either peripheral blood, obtained through tail
snip, or spleen or liver single cells isolated and passed through
a 100-micron pore size nylon mesh. In some experiments,
CD11bhi/CD11c− cells were sort purified from T cell and B cell
depleted spleen samples. Blood samples were smeared on a glass
slide and allowed to dry, spleen and liver cells were placed onto
a glass slide in a drop of RPMI containing 15% mouse serum
and incubated at 37◦C with 5% CO2 for 30min to allow cells to
adhere. For all samples, cells were fixed in methanol for 20min
and stained with Giemsa dye (Azer Scientific, Morgantown, PA)
for 20min and rinsed with ddH2O. In some cases, cells were
incubated with Hz as described in above and Hz is visible as
brown pigment, indicated with arrows. Images were obtained
with a Nikon eclipse Ci light microscope at 100X magnification
or a Zeiss Axio Imager. A1 microscope with an AxioCam MRm
digital camera (Zeiss) at 63 or 96X in oil emersion. Scale bars
were estimated based on average diameter of murine erythrocytes
(Nikon) or with Axiovision SE64 imaging software (Carl Zeiss
Microscopy, LLC, White Plains, NY).
Isolation of P. yoelii-Derived Hemozoin
(PyHz)
Livers and spleens were obtained from mice previously infected
with Py after resolution of acute hyperparasitemia, between
30- and 65-days post-infection. Organs were collected and
homogenized with a tissue homogenizer in de-ionized H2O
(dH2O) and kept on ice for 1 h. Homogenates were centrifuged
at 3,100 × g for 10min. Pellets were washed twice in dH2O and
passed through 100-micron nylon mesh (ELKO Filtering Co.).
Flow-through was collected, washed and resuspended in sterile
PBS before being added to the top of a discontinuous Percoll
density gradient containing 40% (1.07 g/mL) and 80%(1.12
g/mL) fractions. Gradients were centrifuged at 5,000 × g for
20min with slow acceleration/deceleration at 4◦C. Hemozoin
from Py infected mouse organs (PyHz) was collected from the
interphase between the 40 and 80% fractions, as well as from
the dark pellet beneath the 80% fraction. Samples were washed
twice in dH2O and finally resuspended in sterile PBS. Purification
of “clean” PyHz was performed for some experiments with
a method adapted from Coban et al. (2002), where organ
homogenate was lysed in 0.2% IGPAL and washed 3–4 times in
2% sodium dodecyl sulfate (SDS) and then incubated overnight
in 10mM Tris-HCl (pH 8.0), 0.5% SDS, 1mM CaCl2, and 2
mg/mL proteinase K at 37◦C. Next, samples were washed again in
2% SDS and then incubated at 37◦C for 3 h in 6M urea, washed
in 1X PBS and resuspended in saline for experimental use. For
quantification of Hz in mouse tissues, organs were homogenized
and incubated in 1% Proteinase K (VWR, Solon, OH) overnight
at 37◦C. Hz was quantified using a protocol adapted from
Deroost et al. (2012). Briefly, Hz was centrifuged at 3,100 ×
g and pellets were washed three times in 100mM NaHCO3,
pH 9.0 with 2% SDS. Hz, and a dilution series of synthetic
hemozoin (InVivoGen, San Diego, CA) of known concentration,
were resuspended in 100mM NaOH, 2% SDS, 3mM EDTA and
then sonicated for 5min before incubating for 30min at room
temp to dissolve hemozoin into soluble heme. Quantification
was determined by reading absorbance at OD400 and comparing
values of samples prepared from Py-infected mouse organs to
the synthetic Hz standards. For some experiments, PyHz was
incubated at 37◦C in 100 U/mL DNase with 1mM CaCl2 and
2mM MgCl2 for 2 h. These samples were then washed twice in
2mMmannitol-containing phosphate buffer and resuspended in
sterile saline. Absence of DNA in PyHz sample was verified by
staining with GelRed Nucleic Acid stain and running samples on
1% agarose gel.
Plasmodium falciparum Culture and
Preparation of Hemozoin
Natural P. falciparum hemozoin (PfHZ) was prepared from in
vitro human erythrocytes cultures infected with P. falciparum
(Palo Alto strain, mycoplasma-free) treated with DNase
(Sigma, St. Louis, MO). Contamination with endotoxin
(LPS) was excluded by E-Toxate assay (Sigma, St. Louis,
MO), as previously described (Barrera et al., 2011). Briefly,
synchronized parasite cultures were supplemented with
DNase (5 U/ml) 12–15 h previous to schizogony. PfHZ which
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was naturally expelled during schizogony, was harvested at
the 25/40% interface of a discontinuous percoll gradient,
incubated with 40 U/ml DNase, 2mM MgCl2 and 1mM
CaCl2 in PBS at 37
◦C for 1 h and subsequently washed several
times in a 10mM phosphate buffer (pH 8.0) containing
2mM mannitol. HZ was quantified by its heme content
using a luminol-enhanced luminescence assay as previously
described (Schwarzer et al., 1994).
Reactive Oxygen Species Assay
Spleens and blood (for opsonizing bacteria) were collected from
naïve control and Py-infected mice (days 10–16 post infection).
Spleens were processed to generate single cell suspensions. Cells
were plated at 2 × 106 cells/well resuspended in RPMI with 10%
fetal calf serum incubated at 37◦C for 30min with 5% CO2. Cells
were then incubated with the following antibodies; anti-CD3ǫ
APC (clone 145-2C11), anti-CD19 APC (clone 6D5), anti-CD11b
PE/Cy7 (clone M1/70), anti-Ly-6G BV421 (clone 1A8), and 2′,7′-
dichloro-hydrofluorescein diacetate (DCF; Abcam Cambridge,
MA) for 20min. Cells were then left untreated or treated for
20min at 37◦Cwith 5%CO2 with 20µMphorbol 12-myristat 13-
acetate (PMA), unopsonized Lm or Sp, naive serum opsonized
Lm or Sp, or Py serum opsonized Lm or Sp at aMOI of 10. Sp was
heat treated (Ht Sp) at 65◦C for 1 h. Lm andHt Sp were opsonized
in 10% serum, from naïve or Py-infected mice, in RPMI while
incubating at 37◦C and rotating. After treatment, cells were
centrifuged at 300 x g for 5min then incubated at 37◦C for 20min
followed immediately by analysis on a BD LSRFortessa.
Statistical Analysis
Data were analyzed as indicated in each figure legend using
GraphPad Prism v7.
RESULTS
P. yoelii Infection Induces Long-Term
Susceptibility to Bacterial Infections
To examine how Plasmodium may suppress innate immunity
during systemic bacterial infection, C57BL/6N mice were first
infected with Py that resulted in increasing parasitemia through
about 3-weeks post infection that was followed by resolution of
detectable infected RBCs during the ensuing week (Figure 1A).
Control and Py-infected mice were infected intravenously with
the model bacterium Lm 7-days post Py infection followed by
analysis of bacterial burden day 2, 4, 6, and 9 post-Lm infection.
Clearance of Lm was delayed, in particular in the spleen, in Py-
infected mice compared to control mice (Figure 1B). To further
examine increased susceptibility to Lm over the duration of
Py-infection, mice were infected with Lm on day 7, 14, and
28 post-Py infection and spleens were removed 2-days later to
quantify Lm burden. Throughout the course of Py infection,
mice had elevated bacterial burdens (Figure 1C). Remarkably,
increased bacterial burden was also observed at both 1-month
(day 63) and 2-months (day 98) post-clearance of Py infected
RBCs (Figure 1C). Collectively, these data demonstrate that Py
impairs control of Lm infection, which lasts well beyond the
clearance of infected RBCs from peripheral circulation.
Streptococcus pneumoniae (Sp) is one of the most common
bacteria observed in individuals co-infected with malaria and
an invasive bacterial infection (Reddy et al., 2010; Scott et al.,
2011). To formally test the ability of Plasmodium to impair
control of Sp, mice were infected with Py followed by intranasal
Sp infection 7-days later. Following infection, diplococci were
clearly evident in the blood of co-infected mice (Figure 2A),
which showed significantly lower survival through 84-h post Sp
infection compared to control Sp-only infected mice (p= 0.0003;
Figure 2B). Consistent with the decreased survival of Py-infected
mice following Sp infection, bacterial burdens trended higher
in the lungs (Figure 2C) and were significantly higher in both
the blood (Figure 2D) and spleen (Figure 2E). Mice infected
with Sp on day 30 post-Py infection (Figures 2F–H) or day
65–72-post Py infection (Figures 2I–K) had increased bacterial
burdens in lungs, peripheral blood, and spleens compared to age
matched mice infected with only Sp. These data demonstrate
that Py infection also impairs control of Sp bacteremia, and that
the Plasmodium-driven susceptibility to Sp is prevalent beyond
clearance of infected RBCs from peripheral circulation. These
observations led to the hypothesis that Py was impairing one
or more aspects of antibacterial innate immunity that results in
impaired control of these systemic infections.
Impaired Anti-bacterial Immunity Does Not
Correlate With Changes in Splenic Myeloid
Populations
Plasmodium chabaudi infections disrupt splenic architecture and
lead to the loss of marginal zone macrophages (MZMs) and
marginal metalophillic macrophages (MMMs) (Beattie et al.,
2006). As the spleen plays a vital role in the clearance of
bacteria in the blood via these macrophage populations (Aichele
et al., 2003; Lanoue et al., 2004; Aoshi et al., 2009), it led
to the hypothesis that P. yoelii infection results in a loss of
these cell populations and their absence contributes to impaired
clearance of systemic bacterial infections. To test this hypothesis,
mice were infected with Py and various days after infection
spleens were removed for quantification of polymorphonuclear
cells (PMNs), inflammatory monocytes, red pulp macrophages
(RPMs), MZMs, and MMMs (Figure S1). As expected, the
total cellularity of the spleen increased through resolution of
detectable Py infected RBCs, followed by a return to baseline at
1- and 2-months post clearance of Py infected RBCs (Figure 3A).
Analysis of PMNs revealed a consistent expansion in frequency
(Figure 3B) and total number (Figure 3C) of PMNs at days
10, 30–33, and 65–67 post-infection. Whereas, the frequency
of inflammatory monocytes remained consistent between Py-
infected and control mice (Figure 3D), there was an increase
in the total number of these cells at days 10 and 30–33 in Py-
infected mice (Figure 3E). The frequency of RPMs was lower
in Py-infected mice at days 30–33 and 65–67 post-infection
(Figure 3F), yet the total cell numbers remained fairly consistent
during acute parasitemia and following resolution of Py infected
RBCs (Figure 3G). Consistent with the previous report (Beattie
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FIGURE 1 | P. yoelii infection induces long-term suppression of anti-bacterial innate immunity during bacteremia. (A) C57BL/6N mice were infected with 105 Py
pRBCs. Percent parasitemia (percent of RBCs infected with Py) was evaluated during the course of infection. Data (mean ± S.D.) are from nine mice and
representative of three independent experiments. (B) C57BL/6N mice were infected with 105 Py pRBCs, 7 days later both control and Py-infected mice were infected
with 5 × 106 CFU Lm. Lm burden was determined in the spleen and liver on days 2, 3, 6, and 9 post-Lm infection. Data are cumulative results from two-independent
experiments with three or six mice per group per time point. Each symbol represents an individual mouse. Data were analyzed by two-tailed Fisher’s exact test. LOD,
limit of detection. [cfu/spleen day 11 (White et al., 2015) data was originally published in The Journal of Immunology. White C.E., Villarino N.F., Sloan S.S., Ganusov
V.V., and Schmidt N.W. 2015. Plasmodium Suppresses Expansion of T Cell Responses to Heterologous Infections. J. Immunol. 194: 697-708. Copyright © 2015 The
American Association of Immunologists, Inc.] (C) C57BL/6N mice were infected with 105 Py pRBCs. On days 7, 14, 28, 63, and 98 post-Py infection both Py-infected
and control mice were infected with 5 × 106 CFU Lm. Bacterial burdens were determined 2 days post Lm infection. Data (mean ± S.E.) are cumulative results from 2-
to 3-independent experiments with 4–9 mice per group. Data were analyzed with Mann-Whitney test, n.s., not significant.
et al., 2006), we observed a decrease in the frequency (Figure 3H)
and total number (Figure 3I) of MZMs at days 30–33, 65–
67, and 101–102 post-Py infection; however, there was no
difference at day 10 post-Py infection. In contrast, the frequency
(Figure 3J) and total number (Figure 3K) of MMMs remained
fairly consistent following Py infection. Collectively, there is no
consistent increase or decrease in these cell populations that
correlates with impaired clearance of Lm and Sp in Py-infected
mice, suggesting that alternative mechanisms explain increased
bacterial burden following Py infection.
Contribution of P. yoelii-Induced HO-1 and
IL-10 to Impaired Innate Immunity Is
Bacteria-Dependent
Investigations of impaired immunity to non-Typhoid Salmonella
(NTS) co-infections during malaria have reported that the
activities of HO-1 and IL-10, which are produced during
active Plasmodium infection, play an important role in the
increased severity of bacterial infection (Cunnington et al.,
2011; Lokken et al., 2014). To determine whether those
mechanisms are specific to NTS co-infections, we first confirmed
the results of those studies by infecting mice with P. yoelii
followed by co-infection with NTS. Although not statistically
significant, bacterial burdens in coinfected mice with tin
protoporphyrin IX (Sn PP), whichh inhibits HO-I, trended
lower than control. As shown before, P. yoelii-infected mice
treated with an anti-IL-10 monoclonal antibody had reduced
bacterial burdens compared to the respective control treated
mice (Figure S2).
Contrary to observations in NTS co-infections, Sn PP
treatment did not improve anti-bacterial immunity in Py+Lm
(Figure 4A) or Py+Sp (Figure 4C) co-infected groups, as
bacterial burdens of Sn PP treated mice were comparable
to control treated groups. Blocking IL-10 with an anti-IL-10
monoclonal antibody treatment prior to Lm infection did not
improve bacterial clearance in co-infected mice (Figure 4B).
In contrast, anti-IL-10 monoclonal antibody treatment in
Py+Sp co-infected mice was sufficient to significantly reduce
the severity of Pneumococcal infection compared to control
IgG treated Py+Sp mice (Figure 4D). These data demonstrate
that Plasmodium-induced IL-10 is part of the mechanism
by which Py infection impairs control of Sp. The data
also indicate that there may be additional mechanisms by
which Plasmodium infections impair control of systemic
bacterial infections.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 June 2020 | Volume 10 | Article 328
Harding et al. Plasmodium Impairs Innate Antibacterial Immunity
FIGURE 2 | P. yoelii infection increases severity of Pneumococcal infection. C57BL/6N mice were infected (i.v.) with 105 P. yoelii infected RBCs, 7-days later
Py-infected and naïve mice were infected (i.n.) with 106 CFU Streptococcus pneumoniae (Sp). (A) Giemsa stained blood smear from co-infected mouse. Arrows
(Continued)
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FIGURE 2 | indicate Sp diplococci, arrow heads indicate P. yoelii infected RBCs. (B) Survival of mice following Sp infection. Data are pooled results from four
independent experiments with a total of 21 Sp only mice and 25 Py+Sp co-infected mice. Survival data was analyzed by log-rank (Mantel-Cox) test. (C–E) Mice were
sacrificed at either day 3 post Sp infection (10 days post Py infection) or when mice became moribund. Sp burden was quantified in lungs (C), blood (D), and spleen
(E). (C–E) Data (mean ± S.D.) are from a single experiment that is representative of 3 independent experiments with 5–7 mice per group. (F–K) C57BL/6N mice were
infected with 105 P. yoelii infected RBCs, then infected with 106 CFU Sp either 30 (F–H) or 65–72 (I–K) days later. Sp bacterial burdens in blood and organs were
obtained from mice sacrificed 2 days after Sp infection. (F–H) Data (mean ± S.D.) representative of 2 independent experiments with 5–7 mice per group. (I–K) Data
(meat ± S.E.) cumulative results from two independent experiments with 7–10 mice per group. (C–K) Dotted lines indicate limit of detection. Each symbol represents
a single mouse. Statistical significance was determined with Mann-Whitney test.
P. yoelii Impairs Listeria- and
Streptococcus-Induced Reactive Oxygen
Species in Neutrophils
Production of reactive oxygen species (ROS) is an important
antibacterial effector mechanism used by phagocytic cells
that is necessary for immunity to a multitude of bacterial
pathogens (Dinauer, 2005). To determine if impaired ROS
production is a mechanism by which Py suppresses innate
immunity during bacteremia, spleens were removed from
naïve control and Py-infected mice 14–15 days post infection.
ROS production was quantified in whole spleen single cell
suspensions in untreated cells or cells stimulated with PMA,
unopsonized Lm, Lm opsonized with serum from naïve
mice (N-Ops Lm), or Lm opsonized with serum from Py-
infected mice (Py-Ops Lm). In general ROS production
was much more pronounced in Ly-6G+CD11b+ PMNs than
Ly-6G−CD11b+ “macrophages” (Figure 5A). Consistent with
increased Lm burden in Py-infected mice, PMNs from Py-
infected mice showed decreases in intracellular ROS production
(DCF geometric mean fluorescence intensity signal) in each
of the stimulated groups (Figures 5B,C). In contrast, there
was no difference in ROS production in Ly-6G−CD11b+
cells from Py-infected and naïve mice (Figure 5D). Similar
results were also observed when splenocytes were stimulated
with heat-treated (Ht) Sp, Ht N-ops Sp, or Ht Py-ops Sp
(Figure 6).
Additional analysis of the data suggests that Py infection
may impede immunity to Sp, at least in part, through
a serum-dependent effect. As seen in Figure 6C, Ht Sp
opsonized with serum from naive mice (Ht N-ops Sp)
compared to Ht Sp opsonized with serum from Py-infected
mice (Ht Py-ops Sp) elicited increased ROS production in
PMNs from naïve mice (naïve cells treated with Ht N-
Ops Sp vs. naïve cells treated with Ht Py-Ops Sp; open
circle comparison in last two groups; unpaired t-test, p =
0.00087). An even more pronounced serum-dependent effect
was observed in PMNs from Py-infected mice (Py cells
Ht N-Ops Sp vs. Py cells Ht Py-Ops Sp; gray-filled circle
comparison in last two groups; unpaired t-test, p = 0.00042).
Of note, this serum-dependent effect was not observed following
stimulation of Lm (Figure 5C). Collectively, these results
identify impairment of ROS production in neutrophils as a
potential mechanism by which Py suppresses antibacterial innate
immunity during systemic bacterial infections, with an additional





Decreased ROS production suggested that Py infection may
create a permissive environment for invasive bacteria by
suppressing antibacterial effector mechanisms of innate immune
cells. To test the ability of innate immune cells to restrict
intracellular bacterial growth, splenic phagocytes were first
enriched from naïve control and Py-infected (day 9) mice via
depletion of CD3+ and CD19+ cells (Figure 7A) and then
CD11b+CD11c− cells were sort purified (Figure 7B). Analysis
of CD11b+CD11c− splenocytes identified that about half were
Ly-6G+ cells (Naïve = 43.9% ± 3.95; Py-infected day 10 =
52.28% ± 7.40), indicating mixed populations of PMNs and
mononuclear cells in both groups. Sort purified CD11b+CD11c−
cells were infected with Lm in a 5-h gentamycin protection assay.
Curiously, 2 h after infection cells from Py-infected mice had
fewer bacteria than cells from naïve mice (Figure 7C). Whether
this is due to differences in bacterial adherence, uptake, or killing
at this time point is currently unknown. Importantly, 5 h after
infection there was a significant increase in bacteria in cells from
Py-infected mice compared to the 2-h time point as well as the
naïve cell 5-h time point (Figure 7C), resulting in a significant
difference in fold change in intracellular Lm between cells from
naïve vs. Py-infected mice (Figure 7D). Similar results were also
observed when phagocytes were sort-purified 29–35 days post-Py
infection (data not shown).
Degradation of hemoglobin by Plasmodium results in heme,
which is toxic to the parasite. To protect itself from heme,
Plasmodium polymerizes heme into hemozoin (Hz), which is
subsequently released into circulation when the parasite ruptures
out of infected red blood cells (Francis et al., 1997; Pagola
et al., 2000; Egan et al., 2002). Hz has been shown to remain
in host tissues, including the spleen, for many months after the
clearance of infection. This physical characteristic of Hz and
the long-term suppression of innate immunity to bacteremia
following clearance of Py infected RBCs (Figures 1C, 2F–K),
led to the hypothesis that Hz is a parasite-derived factor that
is capable of impairing anti-bacterial effector functions. To test
this, Hz was extracted from spleens and livers of mice that
had cleared Py infected RBCs (PyHz) and incubated with sort
purified splenic phagocytes from naïve mice and then the cells
were infected with Lm in a gentamycin protection assay. This
Hz preparation preserved any associated molecules such as lipids
and/or proteins, which are seen closely bound to Hz in vivo
and have been implicated previously in its immunomodulatory
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FIGURE 3 | P. yoelii-induced temporal changes in splenic myeloid cell populations do not correlate with impaired immunity during bacteremia. C57BL/6N mice were
infected with 105 Py pRBCs. Spleens were collected from control or Py-infected mice on the indicated days post infection. (A) Total numbers of cells per spleen on
(Continued)
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FIGURE 3 | the indicated days. Myeloid cell populations were defined as follows: PMNs (CD3−, CD19−, F4/80−, SIGLEC−, CD11b+, Ly-6G+) (B,C), inflammatory
monocytes (CD3−, CD19−, F4/80−, SIGLEC−, Ly-6G−, CD11b+, CD11c−, Ly-6Chi) (D,E), RPMs (CD3−, CD19−, F4/80hi) (F,G), MZMs (CD3−, CD19−, F4/80−,
SIGLEC−, Ly-6G−, CD11b+, CD11c−, Ly-6Clo, CD209b−, CD169+) (H,I), MMMs (CD3−, CD19−, F4/80−, SIGLEC−, Ly-6G−, CD11b+, CD11c−, Ly-6Clo, CD169−,
CD209b+) (J,K). (B,D,F,J) Percent of splenocytes that are the indicated myeloid cell population. (C,E,G,I,K) Total number of indicated myeloid cell population per
spleen. Data (mean ± S.E.) are combined results from 1* to 3-independent experiments per timepoint with 3–5 mice per group analyzed with t-tests. *Analysis of
MMMs on day 10 post Py infection is a single experiment. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
properties (Schwarzer et al., 2003; Carney et al., 2006).
Following incubation with PyHz, many CD11b+CD11c− cells
had phagocytosed PyHz, while others remained Hz negative
(Figure 7E). Consistent with the hypothesis, PyHz impaired
the ability of CD11b+CD11c− cells to restrict the intracellular
replication of Lm compared to PBS treated cells (Figures 7F,G).
PyHz treated cells contained fewer Lm than untreated cells
2 h after infection, behaving similarly to splenocytes from Py-
infected mice in this assay (Figure 7C). These data demonstrate
that a parasite-derived factor (PyHz) was capable of impairing the
antibacterial effector mechanisms of CD11b+CD11c− cells in an
in vitro assay.
To test whether PyHz was able to impair the clearance
of Lm in vivo, naïve mice were given intravenous injections
of PyHz followed by Lm infection 7-days later. PyHz was
observed in circulating leukocytes both 1- and 7-days post
injection as well as in spleen and liver cells 9-days after
injection (Figure 8A). PyHz could also be quantified in both
the spleen and liver 9-days post PyHz injection (Figure 8B).
When Lm burden was quantified, PyHz treated mice had an
elevated burden in the spleen (Figure 8C). Py is a rodent-
specific species of Plasmodium, and previous studies exploring
immune modulatory effects of Hz have typically isolated Hz
from Plasmodium falciparum infected RBC cultures, rather than
from organs of infected animal. To address potential differences
in isolating Hz from organs of previously infected mice, and
the ability of clinically relevant P. falciparum Hz to suppress
innate immunity during bacteremia, Hz from P. falciparum
infected red blood cell cultures (PfHz) was also tested. Consistent
with Hz from Py infected mice, PfHz could be detected in the
blood following injection (Figure 8D), was quantified in both
the spleen and liver (Figure 8E), and PfHz treated mice had
elevated bacterial burden 2-days post Lm infection (Figure 8F).
Of note, PfHz was treated with DNase to remove DNA whereas
PyHz had not been DNase treated. When PyHz was treated
with DNase to remove DNA, mice injected with DNA free
PyHz still exhibited elevated bacterial burden (Figures S3A–C).
In contrast to these results, mice treated with “clean” PyHz,
which was treated with detergents and proteinase K, followed
by infection with Lm, showed no defect in the control of
Lm (Figure S3D). Similarly, mice that were treated with pure
synthetic Hz followed by Lm infection, also showed no defect
in control of Lm (Figure S3E). Finally, PyHz treated mice
infected with Sp, did not show different bacterial burdens in
the lungs, peripheral blood, or spleen compared to control mice
(Figures 8G–I). Collectively, these results identify Hz with bound
bioactive molecules, excluding DNA, as a parasite-derived factor
that is able to impair anti-bacterial innate immunity to some
bacterial pathogens.
DISCUSSION
Identifying specific cell functions and broad, systemic
deficiencies in innate immune responses during Plasmodium
infections that are responsible for diminished bacterial immunity
is necessary to improve the treatment of these cases. In this
study, we sought to explore the underlying mechanisms of
malaria-induced immune suppression and investigate what
factors contribute to impaired innate immunity to invasive
bacterial infection during both acute Plasmodium infection
and following clearance of infected RBCs. Prior reports on
NTS infections during malaria, demonstrated that infection-
induced IL-10 production and infection-induced hemolysis,
and activation of HO-1, were central to impaired immunity
to NTS (Cunnington et al., 2011, 2012; Lokken et al., 2014).
Here, we show that Plasmodium-induced IL-10 also enhances
susceptibility to Sp co-infection and also demonstrated that
Plasmodium infections can impair innate immunity to bacterial
infections independent of HO-1 and IL-10. In our coinfection
model with NTS we were not able to completely recapitulate
results from Cunnington et al., where they found that inhibiting
HO-1 with Sn PP reduced bacterial burdens in Py-infected mice.
While NTS burdens trended lower in coinfected mice treated
with Sn PP in our model system, differences between treated
and untreated control groups were not statistically significant
(Figure S2A). This may be due to technical differences in our
bacterial inoculum or preparation. Thus, more work is needed
to evaluate the possible role of HO-1 in our Lm and Sp malaria
coinfection models.
It has been postulated that Plasmodium-induced immune
suppression and susceptibility to invasive bacterial infections
is not attributed to a parasite-specific factor. Rather, it is due
to Plasmodium-induced hemolysis, and subsequent activation
of HO-1 and IL-10 that inhibit neutrophil functions lead to
weakened immune responses to invasive bacterial infections
(Mooney et al., 2019). Yet, we demonstrate that Py-induced
immune suppression lasts up to 2-months post clearance of
Py infected RBCs, when the effects of hemolysis are likely
no longer in play. Additionally, Cunnington and colleagues
demonstrated that neutrophils collected from patients previously
infected with P. falciparum had defective ROS burst following
PMA stimulation that lasted up to 8 weeks-post treatment
(Cunnington et al., 2012). Of note, Hz from P. berghei infection
remains deposited in liver, bone marrow, and spleen tissues as
well as within isolated CD11b+ cells isolated from those tissues
and peripheral blood of mice for at least 196 days post infection
(Frita et al., 2012). Collectively, these data provide evidence that
a parasite factor, Hz, may contribute to this impaired innate
immunity to bacterial co-infections and leads to the hypothesis
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FIGURE 4 | Effect of P. yoelii induced HO-1 and IL-10 on susceptibility to invasive bacterial infection is bacteria-specific. (A,B) C57BL/6N mice were infected with 105
Py pRBCs, 7 days later both control and Py-infected mice were infected with 5 × 106 CFU Lm. Spleen and liver bacterial burdens were determined day 2-post Lm
infection. Mice were treated with tin protoporphyrin IX (Sn PP) or PBS control at 48, 24 and 8 h before Lm infection (A), or αIL-10 antibody or isotype control on days
6, 7, and 8 post Py (B). Data (mean ± S.E.) are cumulative results from two independent experiments with 3–6 mice per group analyzed with One-Way ANOVA
followed by Tukey’s multiple comparisons test. (C,D) C57BL/6N mice were infected with 105 Py pRBCs, 8 days later both control and Py-infected mice were infected
i.n. with 5 × 105 CFU Sp. Lung, spleen, and peripheral blood bacterial burdens were determined day 2-post Sp infection. Mice were treated with tin protoporphyrin IX
(Sn PP) or PBS control at 48, 24 and 8 h before Sp infection and 24 h post Sp infection (C), or αIL-10 antibody or isotype control on days 6, 7, and 8 post Py (D). Data
(mean ± S.E.) are cumulative results from two independent experiments with five mice per group and analyzed with One-Way ANOVA followed by an uncorrected
Fischer‘s LSD test with multiple comparisons, n.s., not significant. *p < 0.05, ***p < 0.001, and ****p < 0.0001.
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FIGURE 5 | Splenic PMNs from P. yoelii infected mice have defective ROS production in response to Lm. C57BL/6N mice were infected with 105 Py pRBCs. Single
cell suspensions from whole spleens of naïve and Py-infected mice (days 14 or 15 p.i.) were incubated with DFC to detect intracellular ROS. Cells were then treated
(Continued)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 12 June 2020 | Volume 10 | Article 328
Harding et al. Plasmodium Impairs Innate Antibacterial Immunity
FIGURE 5 | with PMA, Lm, or Lm opsonized with 10% serum from naïve or Py-infected mice. (A) Heat map displays DCF fluorescence in CD11b × Ly6G cells to
indicate amount of intracellular ROS. Heat maps are from an individual mouse in each group that are representative of a single experiment and of three total
independent experiments. (B) Histogram showing DCF fluorescence of splenic PMNs (CD11b+/Ly6G+ ) as shown in box in (A). DCF geometric mean fluorescence
intensity in PMNs (CD11b+/Ly6G+) (C) and macrophages/monocytes (CD11b+/Ly6G−) (D) populations as indicated in (A). Each symbol represents an individual
mouse. Data (mean ± S.D.) are representative of three total independent experiments with three mice per group. Statistical significance was determined with multiple
unpaired t-tests. *p < 0.05 and **p < 0.01.
that this factor contributes to clinical observations of reduced
immunity to invasive bacterial infections in patients with history
of malaria.
Using a murine infection model of malaria and ex vivo
intracellular bacterial survival assays we have determined that
Hz is able to impair innate immunity to bacterial infections
independent of the parasite infection. Of note, we made this
observation using two different preparations of Hz. First, Hz was
prepared via a novel method by extracting Hz from organs of
mice previously infected with Py. Importantly, DNase treated
PyHz, to eliminate parasite and mouse DNA, was still capable
of suppressing innate immunity to Lm in vivo (Figures S3A–C).
Second, we demonstrated natural PfHz prepared from infected
red blood cell cultures (Barrera et al., 2011) was able to
suppress innate immunity in vivo. These data demonstrate
that the immune modulatory effect of PyHz is unlikely due
to parasite or mouse DNA. Whereas, parasite or mouse DNA
were not implicated in the immune suppressive nature of PyHz,
PyHz prepared in the presence of detergents and proteases
(Figure S3D), as well as synthetic Hz (Figure S3E) did not
impair in vivo innate immune responses. This supports the idea
demonstrated by Carney et al. that the immune modulatory
effect of Hz is perhaps not due to Hz itself or adherent
DNA, but attributed to interactions with RBC membrane
lipids and other debris that subsequently generate highly
reactive secondary metabolic products capable of disrupting
cell functions (e.g., NADPH oxidase and iNOS) upon uptake
(Carney et al., 2006). Furthermore, lipids within parasitized
RBCs and hemozoin, such as the hydroxy fatty acids, hydroxy-
arachidonic acid (HETE) and hydroxy-linoleic acid (HODE),
have been shown to inhibit PMA-stimulated reactive oxygen
burst in human peripheral blood monocytes (Schwarzer et al.,
2003).
Our results suggest the possibility that parasite-derived Hz
and bound molecules are contributing to the impaired innate
immune response to Lm, potentially through inhibition of ROS
production.While our data indicate that Hz impairs immunity to
Lm, our “native” preparations of PyHz did not impair immunity
to Sp in our model system. There are two potential explanations
for this observation. First, intravenous injection of PyHz may
not have resulted in sufficient levels of Hz to suppress innate
immunity to Sp. This possibility is supported by the observation
that Py infection impairs innate immunity to Sp long after the
clearance of Py infected RBCs (Figures 2I–K), suggesting a bona
fide role for Hz in this immune suppression. Second, differences
in Hz-driven impaired innate immunity between Lm and Sp
may be explained by the intracellular and extracellular nature of
these pathogens, respectively. Lm is considered an “intracellular
pathogen” since it grows within cells, whereas Sp is generally
thought of as extracellular. Although this is not exclusive as Sp
can grow in CD169+ splenic macrophages (Ercoli et al., 2018).
Our in vitro data demonstrates the impaired anti-bacterial
ability of splenic phagocytes either isolated fromPy-infectedmice
or treated with PyHz. Interestingly, the analysis of intracellular
cfu burdens in our in vitro assay found that splenic phagocytes
from Py-infected mice, or phagocytes treated with PyHz,
contained significantly less Lm at 2 h post infection (with 1 h
in gentamicin) compared to cells from naïve mice or untreated
cells (Figures 7C,F). There are several explanations for this
result, including a defect in Lm uptake, differences in Lm
adherence, and altered killing of intracellular or extracellular
Lm during the time prior to the 2-h time point. Additional
work will be needed to further understand the impact of Py-
infection and hemozoin in these interactions. Furthermore,
cfu counts at 5 h post infection suggest that PyHz treated
or Py-infected mouse phagocytes exhibit a profound inability
to restrict intracellular bacterial growth. In contrast, there
may be a different mechanism responsible for Plasmodium-
dependent susceptibility to extracellular bacteria. For example,
serum-dependent effects as we observed (Figure 6C). This is
discussed below in more detail. Further studies are required to
elucidate the mechanisms underlying susceptibility to Sp and
other extracellular bacterial pathogens during co-infection with
Plasmodium. Methods that can recognize the presence or absence
of internalized Hz at the single cell level would substantially
enhance our understanding of this interaction. Additional work
is also needed to uncover the immune cell types affected as well
as the antimicrobial functions that are impaired by Plasmodium
in the context of Sp and other clinically important co-infections
during malaria.
Hz may directly impair antibacterial effector mechanisms of
innate immune cells via uptake or interaction with Hz. The
uptake and recognition of Hz by phagocytic cells could have
an indirect effect through altering the host microenvironment
via the induction of pathways that influence the production
of cytokines and chemokines in a manner that creates a more
favorable environment for invasive/pathogenic bacteria. Hz has
been shown to induce trained immunity (Schrum et al., 2018),
suggesting the possibility that long-term suppression of innate
immunity to systemic bacterial infections may in part be
attributed Hz-induced epigenetic modifications. CD317+ splenic
dendritic cells purified day 7 post-Py or -Plasmodium chabaudi
infection have been shown to be sufficient at transferring
infection to naïve mice (Wykes et al., 2011). Additionally,
CD317+ dendritic cells purified after initial clearance of patent P.
chabaudi infection, just before recrudescent parasitemia (about
3-weeks post-infection), were also sufficient at causing infection
in naïve mice. While the presence of replicative parasites
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FIGURE 6 | Splenic PMNs from P. yoelii infected mice have defective ROS production in response to heat-killed Sp. C57BL/6N mice were infected with 105 Py
pRBCs. Single cell suspensions from whole spleens of naïve and Py-infected mice (days 14 or 15 p.i.) were incubated with DFC to detect intracellular ROS. Cells were
(Continued)
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FIGURE 6 | then treated with PMA, heat treated Sp (Ht Sp), or Ht Sp opsonized with 10% serum from naïve or Py-infected mice. (A) Heat map displays DCF
fluorescence in CD11b × Ly6G cells to indicate amount of intracellular ROS. Heat maps are from an individual mouse in each group that are representative of a single
experiment and of three total independent experiments. (B) Histogram showing DCF fluorescence of splenic PMNs (CD11b+/Ly6G+ ) as shown in box in (A). DCF
geometric mean fluorescence intensity in PMNs (CD11b+/Ly6G+ ) (C) and macrophages/monocytes (CD11b+/Ly6G− ) (D) populations as indicated in (A). Each
symbol represents an individual mouse. Data (mean ± S.D.) are representative of three total independent experiments with three mice per group. Statistical
significance was determined with multiple unpaired t-tests (D). *p < 0.05 and **p < 0.01.
surviving within splenic DCs has not been described after
resolution of acute hyperparasitemia in Py infection, it is possible
that persistent, undetectable parasites in tissues or circulation
may be contributing to the long-term impaired immunity we
describe in our Py bacterial coinfection models.
Clinical reports of invasive bacterial disease coinciding with
malaria often report both NTS and Sp as the two organisms
most commonly isolated from blood. Experimental studies to
date have focused almost exclusively on NTS and it is unknown
whether the mechanisms of Plasmodium-induced immune
suppression to NTS will be important for Sp or other bacterial
pathogens found in co-infections with malaria (e.g.,Haemophilus
influenzae, Mycobacterium tuberculosis, Staphylococcus aureus,
Streptococcus pyogenes, etc. Berkley et al., 2005; Reddy et al.,
2010; Colombatti et al., 2011; Scott et al., 2011; Were et al.,
2011; Auma et al., 2013; Gomez-Perez et al., 2014; Mourembou
et al., 2016; Morton et al., 2018). We report for the first time,
to our knowledge, a murine Plasmodium and pneumococcal co-
infection. Mice were infected with Plasmodium yoelii 17XNL
followed by a Streptococcus pneumoniae ATCC #6303, a type
3 capsule serotype strain, via the natural intranasal route.
Consistent with the risk of invasive Sp infections in humans
with malaria (Scott et al., 2011), we found decreased survival
and increased bacterial burdens in co-infected mice compared
to control Sp only infected mice. Murine models of malaria
associated-respiratory distress syndrome (MA-ARDS) using
P. berghei NK65 strain have found an association between
pulmonary pathology and the levels of Hz deposition (Deroost
et al., 2013). Pulmonary pathology matching MA-ARDS has
been reported in Py 17X but not Py 17XNL infection (Fu
et al., 2012); however, the parasitemia obtained in mice infected
with Py 17XNL in that study were much lower than what was
observed in this report where Py 17XNL parasitemia reached 40–
60%. Consequently, Hz deposition in the lung, and potentially
in spleen and other organs, may contribute to differential
invasiveness of Sp during Plasmodium infection. Further studies
are necessary to determine to what degree Plasmodium, via
Hz or other mechanisms, induces lung pathology and to what
degree this contributes to increased susceptibility to invasive
Sp infection.
In addition to impaired ROS production, Py infection may
also impair the innate immune response to invasive bacteria
via serum-dependent effects. Complement components C1q
and C3 interact with parasitized RBCs during P. falciparum
infection, initiating the complement cascade, which leads to
reduced serum levels of C1q and lower complement activity
compared to uninfected individuals (Nyakoe et al., 2009; Silver
et al., 2010). Several components of the complement system are
considered essential for immunity to Sp infection, as individuals
with genetic defects in C3, which is involved in both the classical
and alternative complement pathways, experience recurring
pneumococcal infections and infections with other encapsulated
bacteria. Similarly, mice lacking expression of C3, factor B, C1qa,
or C4 genes are more susceptible to Sp infections (Brown et al.,
2002). Moreover, killing of Sp by neutrophils has been shown
to require active complement opsonophagocytosis via CR3
(CD11b/CD18 heterodimer complement receptor; Standish and
Weiser, 2009). Consistent with Plasmodium-induced depletion
of complement and a role for complement in immunity to Sp,
we observed decreased ROS production in splenic PMNs from
naïve mice stimulated with heat-killed Sp opsonized with serum
from Py-infected mice compared to splenic PMNs stimulated
with heat-killed Sp opsonized with serum from naïve mice
(Figures 6A–C). Similarly, PMNs from Py-infected mice showed
increased ROS production following stimulation with heat-killed
Sp opsonized with serum from naïve mice compared to serum
from Py-infected mice. This observation could indicate a serum
factor-dependent defect in neutrophil opsonophagocytosis that
may lead to impaired immunity to Sp during malaria. Although
ROS bursts within neutrophil phagolysosomes are not sufficient
to kill Sp (Standish and Weiser, 2009), deficiency in PMN ROS
production in response to heat-killed Sp opsonized with serum
from Py-infected mice compared to heat-killed Sp opsonized
with serum from naïve mice suggests that phagolysosome
maturation, or other events that follow opsonophagocytosis, may
be inhibited or less responsive. It has also been shown that
serum from febrile P. falciparum infected individuals results
in decreased C3 deposition on NTS compared to serum from
non-febrile P. falciparum negative individuals (Nyirenda et al.,
2018). Collectively, these observations suggest that complement
depletion during Plasmodium infections may be a general
deficiency associated with invasive bacterial infections.
The impact of hemolysis-related immune suppression
initiated by Plasmodium infection (activation of HO-1 and
IL-10) has been well studied in the context of NTS in both animal
models and clinical studies (Cunnington et al., 2012; Lokken
et al., 2014; Mooney et al., 2018). By exploring co-infection
models with different bacterial pathogens during malaria, we
sought to determine whether the IL-10-dependent and HO-1-
dependent mechanisms were specific to NTS co-infection, or if
they also play a role in malaria-related immunosuppression to
other bacterial co-infections. While our results indicated that
HO-1 inhibition with Sn PP failed to improve immunity to either
Lm or Sp co-infections (Figures 4A,C), we did see a reduction in
Sp bacterial burdens in co-infected mice treated with anti-IL-10
(blocking) antibody (Figure 4D). This result is in line with
observations made in influenza and pneumococcal co-infections,
where IL-10 production following influenza virus infection
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FIGURE 7 | P. yoelii infection and parasite-derived hemozoin impairs anti-bacterial functions of splenic phagocytes. (A–C) After C57BL/6N mice were infected with
105 Py pRBCs, splenic phagocytes were enriched from naïve or Py-infected mice day 9 post Py. Magnetic columns were used to enrich for splenic phagocytes by
negative selection of CD3+CD19+ cells. (A) Contour plot showing CD11b and CD11c expression on viable splenocytes prior to T and B cell depletion on magnetic
column. (B) Contour plot showing CD11b and CD11c expression on splenocytes following magnetic column depletion of T and B cells. Circle indicates the population
of splenic phagocytes that was sort purified for gentamicin protection assays. CD11bhiCD11c− cells were then sort purified for experiments. (C,D) 105 sort-purified
CD11bhiCD11c− splenic phagocytes were plated in each well and infected with Lm opsonized with homologous mouse serum with MOI = 100. Intracellular Lm
burden was determined after 2 and 5 h (C) in a gentamicin protection assay to evaluate fold change at 5 h post infection (D). Fold change in intracellular bacteria was
determined by cfu/well at 5 h post infection divided by cfu/well at 2 h post infection. (E–G) 105 sort-purified CD11bhiCD11c− splenic phagocytes were enriched, as in
(A,B), from naïve mice and were incubated with 30 µg hemozoin purified from spleen and livers of mice previously infected with Py (PyHz). (E) A giemsa-stained cell
containing internalized PyHz (brown pigment), indicated by arrow, and PyHz negative cells containing no visible uptaken pigment. Intracellular Lm burden was
determined after 2 and 5 h (F) in a gentamicin protection assay to evaluate fold change at 5 h post infection (G). Fold change in intracellular bacteria was determined
by cfu/well at 5 h post infection divided by cfu/well at 2 h post infection. Data (mean ± S.D.) are representative of three independent experiments each symbol
represents an individual replicate of pooled cells from three mouse spleens per group (naïve or Py-infected). Statistical analysis was determined with Mann-Whitney
test. *p < 0.05 and ***p < 0.001.
disrupts the inflammatory response to Sp in a manner that favors
dissemination and invasive disease (van der Sluijs et al., 2004).
Blocking IL-10 activity in the Py+Sp co-infection may, similarly
to what is seen in the influenza co-infection (van der Sluijs
et al., 2004), result in increased levels of inflammatory factors
in the respiratory tract, such as TNFα and IFNγ, enhanced
PMN infiltration to lungs, and restore the antibacterial immune
response to Sp to normal. IL-10 is known to impair neutrophil
chemotaxis, which may contribute to “neutrophil paralysis” that
has been characterized in samples from patients with P. vivax
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FIGURE 8 | Hemozoin with bound biomolecules is sufficient to impair clearance of Lm in vivo. C57BL/6N mice treated i.v. with 1mg PyHz isolated from livers and
spleens of Py infected mice (A–C) or hemozoin isolated from P. falciparum (Pf) infected red blood cell culture (PfHz) (D–F). Seven days after Hz treatment mice were
infected with 5 × 106 CFUs Lm. (A,D) Giemsa stained peripheral blood smears and cells mounted from spleen and liver single cell suspensions on the indicated days
post Hz treatment. Arrows indicate the presence of intracellular Hz, visible as brown pigment. PyHz and PfHz-negative leukocytes were present at indicated time
points in peripheral blood, spleen or liver with no visible intracellular Hz pigment (B,E). Quantification of Hz in spleens and livers. Data (mean ± S.D.) are from a single
experiment representing three independent experiments. Dotted lines represent the limit of Hz detection. Bacterial burden in spleens of PyHz (C), PfHz (F) or
untreated control mice was determined 2 days post Lm infection. Data (mean ± S.E.) are cumulative results from 2 to 3 independent experiments. Each symbol
represents an individual mouse. (G–I) C57BL/6N mice were treated i.v. with 1–1.5mg PyHz followed by i.n. infection with 106 CFU Sp 7 days later. Mice were
sacrificed 2 days after Sp infection and lungs, blood, and spleens were collected for bacterial burden analysis. Data (mean ± S.E.) are pooled results from three
independent experiments. For all data, each symbol represents an individual mouse. Statistical significance was determined with Mann-Whitney test.
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malaria (Leoratti et al., 2012). Thus, the anti-IL-10 treatments
may have restored neutrophil function, resulting the reduction
in pneumococcal burden in anti-IL-10 treated co-infected mice
compared to isotype-treated controls. While this result shows
that IL-10 is involved in suppressing the immune response to
Sp during Py infection, it likely does not explain the long-term
impaired immunity to Sp we have demonstrated (Figures 2F–K),
since levels of IL-10 decrease following parasite clearance
(Peyron et al., 1994).
This work provides evidence that Plasmodium infections
induce long-term, hemolysis-independent, impaired immunity
to bacterial co-infections and that a parasite factor, hemozoin
with bound bioactive molecules, impairs in vivo clearance of
systemic bacterial infections. Additionally, we find that multiple
Plasmodium-induced mechanisms contribute to susceptibility to
bacterial co-infections, with specific mechanisms dependent on
the particular bacterial pathogen. It is also possible that the
mechanisms of Plasmodium-impaired immune functions impact
different stages in various bacterial infections. Differences in
the three bacterial infections modeled in this work, intravenous,
intranasal and intraperitoneal inoculations for Lm, Sp, and
NTS, respectively, relate to drastically different progressions
of infection, featuring different levels of immune system
bottlenecks. The stage at which each bacterial pathogen is able
to take advantage of these Py-dependent impaired immune
functions to achieve an enhanced infection are therefore likely
to differ depending on the pathogen.
There are currently no effective malaria vaccines that provide
long lasting protection, and the range of malaria transmission
by female Anopheles mosquitoes is predicted to increase with
respect to global climate change (Hertig, 2019). Therefore, the
contribution of hemozoin and impaired serum components
to bacterial infection need be reevaluated and investigated
experimentally to improve our understanding and treatment of
invasive bacterial infection associated with malaria. In particular,
the duration of Hz-dependent impaired innate immunity
following Plasmodium infection needs to be assessed so that a
history of malaria, rather than a positive blood smear during
an active infection, can be considered when assessing a patient’s
risk of developing an invasive bacterial infection to avoid post-
discharge morbidity.
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